-
1
-
-
5444226434
-
Delayed retroperitoneal haematoma after failed lumbar plexus block
-
Aveline C, Bonnet F. Delayed retroperitoneal haematoma after failed lumbar plexus block. Br J Anaesth 2004; 93: 589-91
-
(2004)
Br. J. Anaesth.
, vol.93
, pp. 589-591
-
-
Aveline, C.1
Bonnet, F.2
-
2
-
-
0030828029
-
Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management
-
Horlocker TT, Heit JA. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg 1997; 85: 74-85
-
(1997)
Anesth. Analg.
, vol.85
, pp. 74-85
-
-
Horlocker, T.T.1
Heit, J.A.2
-
4
-
-
0024398566
-
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement
-
Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost 1989; 62: 940-4
-
(1989)
Thromb. Haemost.
, vol.62
, pp. 940-944
-
-
Levine, M.N.1
Planes, A.2
Hirsh, J.3
Goodyear, M.4
Vochelle, N.5
Gent, M.6
-
5
-
-
0028932467
-
Monitoring the anticoagulant effects of a low molecular weight heparin preparation: Correlation assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosis
-
Kessler CM, Esparraguerra IM, Jacobs HM, et al. Monitoring the anticoagulant effects of a low molecular weight heparin preparation: correlation assays in orthopedic surgery patients receiving ardeparin sodium for prophylaxis of deep venous thrombosis. Am Clin Pathol 1995; 103: 642-8
-
(1995)
Am. Clin. Pathol.
, vol.103
, pp. 642-648
-
-
Kessler, C.M.1
Esparraguerra, I.M.2
Jacobs, H.M.3
-
6
-
-
5344247232
-
Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment
-
Kruse MW, Lee JJ. Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment. Am Heart J 2004; 148: 582-9
-
(2004)
Am. Heart J.
, vol.148
, pp. 582-589
-
-
Kruse, M.W.1
Lee, J.J.2
-
7
-
-
0037686713
-
Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation)
-
Horlocker TT, Wedel DJ, Benzon H, et at. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172-97
-
(2003)
Reg. Anesth. Pain Med.
, vol.28
, pp. 172-197
-
-
Horlocker, T.T.1
Wedel, D.J.2
Benzon, H.3
-
8
-
-
2542642293
-
Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment
-
Hulot JS, Vantelon C, Urien S, et at. Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment. Ther Drug Monit 2004; 26: 305-10
-
(2004)
Ther. Drug Monit.
, vol.26
, pp. 305-310
-
-
Hulot, J.S.1
Vantelon, C.2
Urien, S.3
-
9
-
-
0037190688
-
Extended venous thromboembolism prophylaxis after total hip replacement: A comparison of low-molecular-weight heparin with oral anticoagulant
-
SACRE Study Investigators
-
Samama CM, Vray M, Barre J, et al. SACRE Study Investigators. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 2002; 162: 2191-6
-
(2002)
Arch. Intern. Med.
, vol.162
, pp. 2191-2196
-
-
Samama, C.M.1
Vray, M.2
Barre, J.3
|